Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Zentalis Pharmaceuticals Inc shares valued at $29,435 were sold by Epperly Melissa B, on Feb 12 ’24. At $11.44 per share, Epperly Melissa B, sold 2,573 shares. The insider’s holdings dropped to 451,449 shares worth approximately $6.65 million following the completion of this transaction.
Also, Gallagher Cam sold 1,173 shares, netting a total of over 13,419 in proceeds. Following the sale of shares at $11.44 each, the insider now holds 643,277 shares.
Before that, Gallagher Cam had sold 11,552 shares from its account. In a trade valued at $133,310, the President traded Zentalis Pharmaceuticals Inc shares for $11.54 each. Upon closing the transaction, the insider’s holdings decreased to 11,552 shares, worth approximately $9.49 million.
As published in a research note from Wedbush on November 08, 2023, Zentalis Pharmaceuticals Inc [ZNTL] has been rated down from an Outperform to a Neutral and the price target has been revised to $12 from $38. Analysts at Leerink Partners downgraded the stock from ‘”an Outperform”‘ to ‘”a Market perform”‘ outlook in a report released in early November. As of July 12, 2022, Cowen has initiated its “an Outperform” rating for ZNTL. Earlier on April 06, 2022, Wells Fargo initiated its rating. Their recommendation was “an Overweight” for ZNTL stock.
Analyzing ZNTL Stock Performance
During the last five days, there has been a drop of approximately -5.70%. Over the course of the year, Zentalis Pharmaceuticals Inc shares have dropped approximately -2.77%. Shares of the company reached a 52-week high of $18.07 on 02/28/24 and a 52-week low of $10.57 on 02/13/24. A 50-day SMA is recorded $13.78, while a 200-day SMA reached $18.11. Nevertheless, trading volume fell to 0.81 million shares from 0.49 million shares the previous day.
Support And Resistance Levels for Zentalis Pharmaceuticals Inc (ZNTL)
According to the 24-hour chart, there is a support level at 14.28, which, if violated, would cause prices to drop to 13.82. In the upper region, resistance lies at 15.12. The next price resistance is at 15.51. RSI (Relative Strength Index) is 50.68 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.20, which suggests the price will decrease in the coming days. Percent R is at 52.84%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Zentalis Pharmaceuticals Inc subject to short interest?
Stocks of Zentalis Pharmaceuticals Inc saw a sharp rise in short interest on Mar 15, 2024 jumping by 2.41 million shares to 16.74 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 14.33 million shares. A jump of 14.4% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 15.27 of the overall float, the days-to-cover ratio (short ratio) jumped to 15.27.
